{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:47:51Z","timestamp":1791996471787,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bpobgyn.2018.01.017","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:28:51Z","timestamp":1518701331000},"page":"151-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?"],"prefix":"10.1016","volume":"51","author":[{"given":"Paolo","family":"Vercellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Buggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Makieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia Milena","family":"Cribi\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Somigliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2018.01.017_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib2","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/bjc.2014.29","article-title":"Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis","volume":"110","author":"Kim","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib3","article-title":"Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study","author":"Saraswat","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9378(97)70550-7","article-title":"Cancer risk after a hospital discharge diagnosis of endometriosis","volume":"176","author":"Brinton","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/humrep\/dei462","article-title":"Endometriosis and the risk of cancer with special emphasis on ovarian cancer","volume":"21","author":"Melin","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan","volume":"17","author":"Kobayashi","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejogrb.2007.06.017","article-title":"Ovarian endometrioma\u2013risks factors of ovarian cancer development","volume":"138","author":"Kobayashi","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib8","first-page":"1357","article-title":"Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery","volume":"19","author":"Rossing","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/aogs.12123","article-title":"Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer","volume":"92","author":"Melin","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","article-title":"New insights in the pathophysiology of ovarian cancer and implications for screening and prevention","volume":"213","author":"Nezhat","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib14","first-page":"12","article-title":"Research on the menopause in the 1990's. Report of a WHO Scientific group","volume":"866","author":"World Health Organization","year":"1996","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00042192-200007010-00003","article-title":"Clinical challenges of perimenopause: consensus opinion of the North American menopause society","volume":"7","author":"North American Menopause Society","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpobgyn.2014.04.010","article-title":"Imaging for the evaluation of endometriosis and adenomyosis","volume":"28","author":"Exacoustos","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/uog.15955","article-title":"Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group","volume":"48","author":"Guerriero","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/humrep\/dew113","article-title":"Age-related differences in the sonographic characteristics of endometriomas","volume":"31","author":"Guerriero","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib19","first-page":"25","article-title":"Management of endometriomas","volume":"35","author":"Muzii","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.4934","article-title":"Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?","volume":"243","author":"Cochrane","year":"2017","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2012.04.021","article-title":"Clear cell carcinoma of the ovary: a review of the literature","volume":"126","author":"del Carmen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bpobgyn.2016.08.007","article-title":"Pathology of borderline and invasive cancers","volume":"41","author":"Prat","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib23","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","article-title":"ARID1A mutations and PI3K\/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas","volume":"14","author":"Samartzis","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GRF.0000000000000320","article-title":"Endometriosis-associated ovarian cancers","volume":"60","author":"Anglesio","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12885-017-3601-1","article-title":"Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis","volume":"17","author":"Chan","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/mi.10.3.3","article-title":"A\u00a0new class of estrogen receptor beta-selective activators","volume":"10","author":"Lo","year":"2010","journal-title":"Mol Interv"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an ovarian tumor tissue analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2014.03.017","article-title":"Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study","volume":"133","author":"Scarfone","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib30","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","article-title":"ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers","volume":"71","author":"Guan","year":"2011","journal-title":"Cancer Res"},{"issue":"363","key":"10.1016\/j.bpobgyn.2018.01.017_bib31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"14","author":"Wiegand","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib33","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IGC.0b013e31826b5dcc","article-title":"Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma","volume":"22","author":"Ayhan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IGC.0000000000000698","article-title":"BAF250a Expression in atypical endometriosis and endometriosis-associated ovarian cancer","volume":"26","author":"Stamp","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IGC.0b013e318231f140","article-title":"Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers","volume":"22","author":"Lowery","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/07357907.2012.681821","article-title":"Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities","volume":"30","author":"Shigetomi","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2407-14-120","article-title":"A\u00a0functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A\/BAF250a is associated with AKT phosphorylation","volume":"14","author":"Wiegand","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.4516","article-title":"Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden","volume":"236","author":"Anglesio","year":"2015","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib39","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/humrep\/der211","article-title":"The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/humupd\/dmt053","article-title":"The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary","volume":"20","author":"Sanchez","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/humrep\/det466","article-title":"Iron availability is increased in individual human ovarian follicles in close proximity to an endometrioma compared with distal ones","volume":"29","author":"Sanchez","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejogrb.2016.01.032","article-title":"Characteristics of follicular fluid in ovaries with endometriomas","volume":"209","author":"Giacomini","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1179\/1351000215Y.0000000038","article-title":"Potential scenarios leading to ovarian cancer arising from endometriosis","volume":"21","author":"Kobayashi","year":"2016","journal-title":"Redox Rep"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2012.05.007","article-title":"Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience","volume":"126","author":"Mangili","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib45","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1309\/AJCPZ5T2POOFMQVN","article-title":"Distinct \u03b2-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas","volume":"144","author":"Matsumoto","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmi037","article-title":"Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis","volume":"12","author":"Vigan\u00f3","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib48","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.humpath.2011.10.009","article-title":"KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis","volume":"43","author":"Stewart","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib49","first-page":"7052","article-title":"Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary","volume":"60","author":"Sato","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/humrep\/det387","article-title":"Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study","volume":"29","author":"Govatati","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib51","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/modpathol.2011.217","article-title":"Loss of ARID1A\/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?","author":"Samartzis","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib52","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-associated mutations in endometriosis without cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib53","doi-asserted-by":"crossref","first-page":"78263","DOI":"10.18632\/oncotarget.21051","article-title":"Endometriosis: benign, malignant, or something in between?","volume":"8","author":"Chui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/aogs.13010","article-title":"Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review","volume":"96","author":"Thomsen","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cdp.2006.09.002","article-title":"Precancer: a conceptual working definition \u2013 results of a Consensus Conference","volume":"30","author":"Berman","year":"2006","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib56","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.fertnstert.2013.02.002","article-title":"The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions","volume":"99","author":"Vercellini","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0036-1597120","article-title":"Cancer implications for patients with endometriosis","volume":"35","author":"Wilbur","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib58","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/GRF.0000000000000314","article-title":"Pathology of ovarian cancer: recent insights unveiling opportunities in prevention","volume":"60","author":"Kommoss","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/gyno.2000.5765","article-title":"Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study","volume":"77","author":"Ogawa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib60","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/01443615.2015.1065234","article-title":"Carcinoma of the recto-vaginal septum. Comprehensive literature review","volume":"36","author":"Lopez","year":"2016","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000449198","article-title":"Malignant transformation of vaginal endometriosis - a review of literature","volume":"82","author":"Cozzolino","year":"2017","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/modpathol.2016.219","article-title":"Steroid hormone synthesis by the ovarian stroma surrounding epithelial ovarian tumors: a potential mechanism in ovarian tumorigenesis","volume":"30","author":"Blanco","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib63","first-page":"45","article-title":"Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China","volume":"10","author":"He","year":"2017","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib64","article-title":"Factors that differentiate between endometriosis-associated ovarian cancer and benign ovarian endometriosis with mural nodules","author":"Tanase","year":"2017","journal-title":"Magn Reson Med Sci"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000357819","article-title":"Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma","volume":"77","author":"Taniguchi","year":"2014","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tjog.2015.09.009","article-title":"Unexpected epithelial ovarian cancers arising from presumed endometrioma: a 10-year retrospective analysis","volume":"56","author":"Kuo","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jum.14197","article-title":"First international consensus report on adnexal masses: management recommendations","volume":"36","author":"Glanc","year":"2017","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib68","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib69","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2016.07.1077","article-title":"Development of ovarian cancer after excision of endometrioma","volume":"106","author":"Haraguchi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib70","first-page":"1","article-title":"Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment","volume":"6","author":"Vercellini","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib71","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GCO.0b013e3283558539","article-title":"Ovarian remnant syndrome: etiology, diagnosis, treatment and impact of endometriosis","volume":"24","author":"Kho","year":"2012","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib72","article-title":"Management of endometriosis: toward value-based, cost-effective, Affordable care","author":"Vercellini","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0412.2012.01470.x","article-title":"Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis","volume":"92","author":"Vercellini","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib74","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.fertnstert.2015.08.026","article-title":"Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis","volume":"104","author":"Koga","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1471-0528.2008.02055.x","article-title":"'Blood on the Tracks' from corpora lutea to endometriomas","volume":"116","author":"Vercellini","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajog.2004.03.035","article-title":"Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis","volume":"191","author":"Modugno","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib77","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/annonc\/mdw306","article-title":"Global trends and predictions in ovarian cancer mortality","volume":"27","author":"Malvezzi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib78","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1055-9965.EPI-14-1128","article-title":"Population distribution of lifetime risk of ovarian cancer in the United States","volume":"24","author":"Pearce","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib80","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2015.10.001","article-title":"Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women","volume":"139","author":"Manchanda","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib81","series-title":"Endometriosis: diagnosis and management. NICE guideline NG73","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib82","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/gyno.1996.0032","article-title":"Histologic transformation of benign endometriosis to early epithelial ovarian cancer","volume":"60","author":"Sainz de la Cuesta","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0301-2115(03)00367-1","article-title":"Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis","volume":"113","author":"Cuesta","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/PAP.0b013e3180ca7d7b","article-title":"The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects","volume":"14","author":"Clement","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jms.8.1.1","article-title":"The definition of screening","volume":"8","author":"Wald","year":"2001","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib86","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2016.02.020","article-title":"Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial","volume":"141","author":"Narod","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib87","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, Lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib88","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","article-title":"Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up","volume":"143","author":"Pinsky","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib89","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib90","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib91","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.21894","article-title":"Screening for ovarian cancer in asymptomatic women","volume":"319","author":"Lu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2018.01.017_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijsu.2008.11.005","article-title":"Communicating the benefits, harms and risks of medical interventions: in journals; to patients and public","volume":"7","author":"Thornton","year":"2009","journal-title":"Int J Surg"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341830035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169341830035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:09:10Z","timestamp":1761498550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169341830035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":92,"alternative-id":["S152169341830035X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.01.017","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2018.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}